Patients could benefit from more effective, higher quality and longer lasting medicines as the UK sets out a clearer route to bring drugs manufactured in space safely to market.
Similar Posts
Field Safety Notices: 1 to 5 September 2025
List of Field Safety Notices from 1 to 5 September 2025.
MHRA phase I accreditation scheme
How to join the phase I accreditation scheme.
Field Safety Notices: 15 to 19 September 2025
List of Field Safety Notices from 15 to 19 September 2025.
MHRA approves tisotumab vedotin for the treatment of cervical cancer
As with all licensed medicines, we will continue to monitor its safety closely as it becomes more widely used
Project Orbis
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Side effects from drug interactions to be predicted by AI before reaching patients
The MHRA leads three new government-backed projects using AI-driven approaches to make medicines safer and bring treatments to patients more quickly.